Previous 10 | Next 10 |
2023-12-12 08:39:32 ET Losers: Achieve Life Sciences ( ACHV ) -24% announces participation at upcoming investor conferences. Clearmind Medicine CMND -13% files for $50M mixed shelf . Oracle Corp. ORCL -10% after Q2 earnings release . Acurx Pharmaceu...
2023-12-11 16:53:07 ET DENVER, Colo., Dec. 11, 2023 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; Marker Therapeutics, Inc. (NASDAQ: MRKR), Poseida Therapeutics (NASDAQ: PSTX), Assure Holdings (NASDAQ: IONM), Jet AI (NASDAQ: JTAI), and NextPlay Techn...
2023-12-11 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Veru, Kodiak S...
2023-12-11 09:56:01 ET DENVER, Colo., Dec. 11, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Pasithea Therapeutics Corp (NASDAQ: KTTA), Poseida Therapeutics, Inc. (NASDAQ: PSTX), Onconova Therapeutics I...
2023-12-11 09:08:24 ET DENVER, Colo., Dec. 11, 2023 ( www.247marketnews.com )- Companies mentioned include Macy’s Inc (NYSE: M), Siyata Mobile (NASDAQ: SYTA), Assure Holdings Corp (NASDAQ: IONM), and Poseida Therapeutics, Inc. (NASDAQ: PSTX). Macy’s Inc (NYSE: M) is tr...
2023-12-11 08:02:38 ET DENVER, Colo., Dec 11, 2023 ( www.247marketnews.com )- Poseida Therapeutics, Inc. (NASDAQ: PSTX) reported, Sunday evening, early efficacy and safety results from its Phase 1 study of P-BCMA-ALLO1, its BCMA-targeted allogeneic, T stem cell memory (TSCM)-r...
Poseida Therapeutics Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting PR Newswire 82% ORR and deep clinical responses from off-the...
2023-11-20 17:34:17 ET Symbotic ( SYM ) +20% . Veradigm ( MDRX ) +6% . Tactile Systems Technology ( TCMD ) +6% . Farmer Brothers Company ( FARM ) +4% . Outset Medical ( OM ) +4% . MorphoSys ( MOR ) -32% ...
2023-11-17 13:08:02 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The article embarks on a transformative journey through the biotech frontier, where the listed companies stand as titans reshaping healthcare norms. The first one’s strategic collabo...
2023-11-10 10:48:08 ET More on Poseida Therapeutics Poseida Therapeutics: Why I Am Still Holding On To The Stock Into 2024 (Rating Downgrade) Poseida Therapeutics' Financial And Clinical Milestones Signal Upgrade To 'Strong Buy' Poseida Therapeutics, Inc. 2023 Q2 - R...
News, Short Squeeze, Breakout and More Instantly...
Poseida Therapeutics Inc. Company Name:
PSTX Stock Symbol:
NASDAQ Market:
Poseida Therapeutics Inc. Website:
Poseida Therapeutics Announces Participation in Stifel's 2024 Virtual Cell Therapy Forum PR Newswire SAN DIEGO , July 1, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advanci...
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders PR Newswire SAN DIEGO , June 3, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differ...
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024 PR Newswire Expanded strategic relationship with Astellas with new research collaboration leveraging Poseida's proprietary allogeneic CAR-T platform to develop cell therapies targeti...